DK1399430T3 - Oxazol/thiazolderivataktivatorer af HPPAR-alfa-receptoren - Google Patents

Oxazol/thiazolderivataktivatorer af HPPAR-alfa-receptoren

Info

Publication number
DK1399430T3
DK1399430T3 DK02747331T DK02747331T DK1399430T3 DK 1399430 T3 DK1399430 T3 DK 1399430T3 DK 02747331 T DK02747331 T DK 02747331T DK 02747331 T DK02747331 T DK 02747331T DK 1399430 T3 DK1399430 T3 DK 1399430T3
Authority
DK
Denmark
Prior art keywords
oxazole
alpha receptor
thiazole derivative
hppar alpha
activators
Prior art date
Application number
DK02747331T
Other languages
English (en)
Inventor
Francoise Jeanne Gellibert
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Application granted granted Critical
Publication of DK1399430T3 publication Critical patent/DK1399430T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyridine Compounds (AREA)
DK02747331T 2001-05-31 2002-05-29 Oxazol/thiazolderivataktivatorer af HPPAR-alfa-receptoren DK1399430T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0113231.5A GB0113231D0 (en) 2001-05-31 2001-05-31 Chemical compounds
PCT/EP2002/005886 WO2002096895A1 (en) 2001-05-31 2002-05-29 Oxazol/ thiazol-derivatives activators of the hppar-alpha receptor

Publications (1)

Publication Number Publication Date
DK1399430T3 true DK1399430T3 (da) 2008-03-25

Family

ID=9915636

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02747331T DK1399430T3 (da) 2001-05-31 2002-05-29 Oxazol/thiazolderivataktivatorer af HPPAR-alfa-receptoren

Country Status (28)

Country Link
US (1) US7157479B2 (da)
EP (1) EP1399430B1 (da)
JP (1) JP2004532267A (da)
KR (1) KR100859591B1 (da)
CN (1) CN1307166C (da)
AR (1) AR034051A1 (da)
AU (1) AU2002317765B2 (da)
BR (1) BR0209785A (da)
CA (1) CA2448205A1 (da)
CO (1) CO5540297A2 (da)
CY (1) CY1107206T1 (da)
CZ (1) CZ20033252A3 (da)
DE (1) DE60223805T2 (da)
DK (1) DK1399430T3 (da)
ES (1) ES2296965T3 (da)
GB (1) GB0113231D0 (da)
HU (1) HUP0400043A3 (da)
IL (1) IL158929A0 (da)
MX (1) MXPA03011032A (da)
MY (1) MY132656A (da)
NO (1) NO20035209L (da)
NZ (1) NZ529754A (da)
PL (1) PL367248A1 (da)
PT (1) PT1399430E (da)
SI (1) SI1399430T1 (da)
TW (1) TWI245760B (da)
WO (1) WO2002096895A1 (da)
ZA (1) ZA200309095B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1445258E (pt) * 2001-10-12 2009-07-02 Nippon Chemiphar Co Activador para o receptor delta activado por proliferador de peroxissoma
AU2003261935A1 (en) 2002-09-06 2004-03-29 Takeda Pharmaceutical Company Limited Furan or thiophene derivative and medicinal use thereof
GB0314370D0 (en) * 2003-06-19 2003-07-23 Glaxo Group Ltd Chemical compounds
GB0323702D0 (en) * 2003-10-09 2003-11-12 Smithkline Beecham Corp Chemical compound
AU2004291262C1 (en) 2003-11-05 2011-08-11 F. Hoffmann-La Roche Ag Phenyl derivatives as PPAR agonists
FR2882359A1 (fr) * 2005-02-24 2006-08-25 Negma Lerads Soc Par Actions S Derives activateurs de ppar, procede de preparation et application en therapeutique
CN101007790B (zh) * 2006-01-27 2011-03-30 北京摩力克科技有限公司 草氨酸衍生物、其制备方法和医药用途
FR2901792A1 (fr) * 2006-06-06 2007-12-07 Negma Lerads Soc Par Actions S DERIVES ACTIVATEURS DE PPARs, PROCEDE DE PREPARATION ET APPLICATION EN THERAPEUTIQUE
TW201022221A (en) * 2008-12-01 2010-06-16 Mitsubishi Tanabe Pharma Corp Carboxylic acid derivatives containing thiazole ring and pharmaceutical use thereof
CN110803996B (zh) * 2019-11-13 2022-01-11 台州市创源工业技术有限公司 一种羟基苄胺的合成方法
CN116511225B (zh) * 2023-03-30 2025-09-23 江南大学 一种油酸基des液体及其制备方法和它在厌氧发酵液高效浓缩中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1233241A (zh) 1996-08-19 1999-10-27 日本烟草产业株式会社 丙酸衍生物及其用途
ATE451346T1 (de) * 1998-03-10 2009-12-15 Ono Pharmaceutical Co Carbonsäurederivate und medikamente die diese als aktiven wirkstoff enthalten
PL351470A1 (en) * 1999-04-28 2003-04-22 Aventis Pharma Gmbh Tri-aryl acid derivatives as ppar receptor ligands
GB9914977D0 (en) 1999-06-25 1999-08-25 Glaxo Group Ltd Chemical compounds
US6417212B1 (en) 1999-08-27 2002-07-09 Eli Lilly & Company Modulators of peroxisome proliferator activated receptors
PE20011010A1 (es) * 1999-12-02 2001-10-18 Glaxo Group Ltd Oxazoles y tiazoles sustituidos como agonista del receptor activado por el proliferador de peroxisomas humano
GB0113233D0 (en) * 2001-05-31 2001-07-25 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
DE60223805T2 (de) 2008-10-30
ZA200309095B (en) 2005-02-21
CO5540297A2 (es) 2005-07-29
NO20035209D0 (no) 2003-11-24
PT1399430E (pt) 2008-02-19
AU2002317765B2 (en) 2005-02-03
KR100859591B1 (ko) 2008-09-23
HUP0400043A2 (hu) 2004-04-28
IL158929A0 (en) 2004-05-12
CZ20033252A3 (en) 2004-03-17
HK1064367A1 (en) 2005-01-28
PL367248A1 (en) 2005-02-21
WO2002096895A1 (en) 2002-12-05
AR034051A1 (es) 2004-01-21
US20050070517A1 (en) 2005-03-31
NZ529754A (en) 2005-12-23
HUP0400043A3 (en) 2008-03-28
GB0113231D0 (en) 2001-07-25
TWI245760B (en) 2005-12-21
CA2448205A1 (en) 2002-12-05
EP1399430B1 (en) 2007-11-28
ES2296965T3 (es) 2008-05-01
KR20040007632A (ko) 2004-01-24
MY132656A (en) 2007-10-31
DE60223805D1 (de) 2008-01-10
SI1399430T1 (sl) 2008-04-30
CY1107206T1 (el) 2012-11-21
JP2004532267A (ja) 2004-10-21
CN1307166C (zh) 2007-03-28
NO20035209L (no) 2004-01-27
MXPA03011032A (es) 2004-03-19
US7157479B2 (en) 2007-01-02
BR0209785A (pt) 2004-06-01
EP1399430A1 (en) 2004-03-24
CN1633421A (zh) 2005-06-29

Similar Documents

Publication Publication Date Title
DK1244642T3 (da) Substituerede oxazol- og thiazolderivater som HPPAR-alfa-aktivatorer
NO20010628D0 (no) Substituerte oksazol- og thiazolderivater som hPPAR <gamma> og hPPAR <alfa> aktivatorer
DE60323060D1 (de) Thiazol- und oxazolderivaten als ppar modulatoren
DK1531814T3 (da) Sustained-release tabletkomposition af pramipexol
DK1349843T3 (da) Thiazol- og oxazolderivater som aktivatorer af human peroxisom profilerator-aktiverede receptorer
DK1343773T3 (da) Thiazolderivater til behandling af PPAR-beslægtede forstyrrelser
DK1453512T3 (da) Acetylenderivater med mGluR5 antagonistisk virkning
ATE391505T1 (de) Benzothiazole derivative
NO20025978L (no) Benzotiazol-derivater
ATE302762T1 (de) Oxazolidinon-thioamide mit piperazinamid- substituenten
DK1380121T3 (da) Fremgangsmåde til fremstilling af oxazolidinoner
DK1399430T3 (da) Oxazol/thiazolderivataktivatorer af HPPAR-alfa-receptoren
NO20042737L (no) Peroksisomproliferatoraktiverte receptoragonister
DE60316746D1 (de) Keramischer Suszeptor
ATE444290T1 (de) Oxazolderivate von tetracyclinen
DK1464641T3 (da) 4-phenylpiperazinyl-, -piperidinyl- og -tetrahydropyridylderivater som dopamin-D4-antagonister
DE60142038D1 (de) Aktivatoren des peroxisome proliferator-activated rezeptors
DE60300602D1 (de) Thiazole Derivate enthaltende härtbare Zusammensetzung
DE60212694D1 (de) Benzothiazolderivaten
ATE309242T1 (de) Benzothiazole
NO20032582D0 (no) 1,2,4-oksadiazolderivater som HPPAR alfa agonister
ATE329913T1 (de) Oxazole als mglur1 verstärker
DK1383763T3 (da) Fremgangsmåde til fremstilling af 2-(-5-(4-fluorphenyl)-3-pyridylmethylaminomethyl)-chroman
DE50001813D1 (de) Substituierte benzoxazole
ITTO20040893A1 (it) Dispositivo perfezionato per l'esecuzione di docce a temperature alternate